Optimal cefepime and meropenem dosing for ventilator-associated pneumonia patients with reduced renal function: an update to our clinical pathway.
Kuti
Joseph L
JL
Nicolau
David P
DP
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000077723:Cefepime; D002511:Cephalosporins / Q000008:administration & dosage*; D003404:Creatinine / Q000378:metabolism; D019091:Critical Pathways; D004334:Drug Administration Schedule; D006801:Humans; D000077731:Meropenem; D053717:Pneumonia, Ventilator-Associated / Q000150:complications / Q000188:drug therapy*; D011785:Quality Assurance, Health Care; D051437:Renal Insufficiency / Q000150:complications*; D013845:Thienamycins / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D000077723:Cefepime; D003404:Creatinine; D000077731:Meropenem